- Home
- SERV vs VIR Comparison
SERV vs VIR Comparison
Compare SERV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERV
- VIR
- Stock Information
- Founded
- SERV 2017
- VIR 2016
- Country
- SERV United States
- VIR United States
- Employees
- SERV N/A
- VIR N/A
- Industry
- SERV Industrial Specialties
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- SERV Consumer Discretionary
- VIR Health Care
- Exchange
- SERV Nasdaq
- VIR Nasdaq
- Market Cap
- SERV 682.1M
- VIR 706.4M
- IPO Year
- SERV N/A
- VIR 2019
- Fundamental
- Price
- SERV $10.26
- VIR $5.65
- Analyst Decision
- SERV Strong Buy
- VIR Strong Buy
- Analyst Count
- SERV 4
- VIR 8
- Target Price
- SERV $17.00
- VIR $30.25
- AVG Volume (30 Days)
- SERV 5.0M
- VIR 1.2M
- Earning Date
- SERV 08-12-2025
- VIR 07-31-2025
- Dividend Yield
- SERV N/A
- VIR N/A
- EPS Growth
- SERV N/A
- VIR N/A
- EPS
- SERV N/A
- VIR N/A
- Revenue
- SERV $1,306,237.00
- VIR $20,861,000.00
- Revenue This Year
- SERV $298.51
- VIR N/A
- Revenue Next Year
- SERV $586.63
- VIR $0.62
- P/E Ratio
- SERV N/A
- VIR N/A
- Revenue Growth
- SERV 17.26
- VIR N/A
- 52 Week Low
- SERV $2.23
- VIR $4.32
- 52 Week High
- SERV $24.35
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- SERV N/A
- VIR 57.21
- Support Level
- SERV N/A
- VIR $5.20
- Resistance Level
- SERV N/A
- VIR $6.23
- Average True Range (ATR)
- SERV 0.00
- VIR 0.30
- MACD
- SERV 0.00
- VIR 0.07
- Stochastic Oscillator
- SERV 0.00
- VIR 56.06
About SERV Serve Robotics Inc. Common Stock
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.